{"drugs":["Piperaquine Tetraphosphate\/Dihydroartemisinin"],"mono":{"0":{"id":"930413-s-0","title":"Generic Names","mono":"Piperaquine Tetraphosphate\/Dihydroartemisinin"},"1":{"id":"930413-s-1","title":"Dosing and Indications","sub":[{"id":"930413-s-1-4","title":"Adult Dosing","mono":"<ul><li>piperaquine\/dihydroartemisinin has centralized marketing authorization by the European Medicines Agency (EMA) for use in the European Union (EU)<\/li><li><b>Falciparum malaria:<\/b> (24 to less than 36 kg) piperaquine 640 mg\/dihydroartemisinin 80 mg ORALLY once daily for 3 days; MAX not to exceed 3 courses in 12 months; if needed, start second course at least 2 months after completing first course (European Medicines Agency-approved dosing)<\/li><li><b>Falciparum malaria:<\/b> (36 to less than 75 kg) piperaquine 960 mg\/dihydroartemisinin 120 mg ORALLY once daily for 3 days; MAX not to exceed 3 courses in 12 months; if needed, start second course at least 2 months after completing first course (European Medicines Agency-approved dosing)<\/li><li><b>Falciparum malaria:<\/b> (75 to less than 100 kg) piperaquine 1280 mg\/dihydroartemisinin 160 mg ORALLY once daily for 3 days; MAX not to exceed 3 courses in 12 months; if needed, start second course at least 2 months after completing first course (European Medicines Agency-approved dosing)<\/li><\/ul>"},{"id":"930413-s-1-5","title":"Pediatric Dosing","mono":"<ul><li>piperaquine\/dihydroartemisinin has centralized marketing authorization by the European Medicines Agency (EMA) for use in the European Union (EU)<\/li><li>safety and efficacy not established in pediatric patients younger than 6 months or in pediatric patients weighing less than 5 kg<\/li><li><b>Falciparum malaria:<\/b> (5 to less than 7 kg) piperaquine 80 mg\/dihydroartemisinin 10 mg ORALLY once daily for 3 days; MAX not to exceed 3 courses in 12 months; if needed, start second course at least 2 months after completing first course (European Medicines Agency-approved dosing)<\/li><li><b>Falciparum malaria:<\/b> (7 to less than 13 kg) piperaquine 160 mg\/dihydroartemisinin 20 mg ORALLY once daily for 3 days; MAX not to exceed 3 courses in 12 months; if needed, start second course at least 2 months after completing first course (European Medicines Agency-approved dosing)<\/li><li><b>Falciparum malaria:<\/b> (13 to less than 24 kg) piperaquine 320 mg\/dihydroartemisinin 40 mg ORALLY once daily for 3 days (European Medicines Agency-approved dosing); MAX not to exceed 3 courses in 12 months; if needed, start second course at least 2 months after completing first course<\/li><li><b>Falciparum malaria:<\/b> (24 to less than 36 kg) piperaquine 640 mg\/dihydroartemisinin 80 mg ORALLY once daily for 3 days; MAX not to exceed 3 courses in 12 months; if needed, start second course at least 2 months after completing first course (European Medicines Agency-approved dosing)<\/li><li><b>Falciparum malaria:<\/b> (36 to less than 75 kg) piperaquine 960 mg\/dihydroartemisinin 120 mg ORALLY once daily for 3 days; MAX not to exceed 3 courses in 12 months; if needed, start second course at least 2 months after completing first course (European Medicines Agency-approved dosing)<\/li><li><b>Falciparum malaria:<\/b> (75 to less than 100 kg) piperaquine 1280 mg\/dihydroartemisinin 160 mg ORALLY once daily for 3 days; MAX not to exceed 3 courses in 12 months; if needed, start second course at least 2 months after completing first course (European Medicines Agency-approved dosing)<\/li><\/ul>"},{"id":"930413-s-1-6","title":"Dose Adjustments","mono":"<b>vomiting:<\/b> if vomiting occurs within 30 minutes of administration, then re-administer dose; if vomiting occurs between 30 to 60 minutes of administration, then re-administer one-half the dose; if vomiting occurs after second dose, then find alternative therapy; do not re-administer more than once "},{"id":"930413-s-1-7","title":"Indications","mono":"<b>Non-FDA Labeled Indications<\/b><br\/>Falciparum malaria<br\/>"}]},"3":{"id":"930413-s-3","title":"Contraindications\/Warnings","sub":[{"id":"930413-s-3-9","title":"Contraindications","mono":"<ul><li>arrhythmias, symptomatic, or with clinically relevant bradycardia<\/li><li>cardiac conditions predisposing for arrhythmia, including severe hypertension, left ventricular hypertrophy (including hypertrophic cardiomyopathy), or congestive cardiac failure with reduced left ventricular ejection fraction<\/li><li>concomitant use or recent use (if still in system circulation) with QT-prolonging agents<\/li><li>electrolyte disturbances, especially hypokalemia, hypocalcemia, or hypomagnesemia<\/li><li>hypersensitivity to piperaquine, dihydroartemisinin, or any component of the product<\/li><li>malaria, severe (WHO definition)<\/li><li>QT prolongation, congenital, or sudden death, family history<\/li><li>QT prolongation, congenital, or any condition known to prolong the QT interval<\/li><\/ul>"},{"id":"930413-s-3-10","title":"Precautions","mono":"<ul><li>breastfeeding during therapy; not recommended<\/li><li>concomitant use with grapefruit juice should be avoided<\/li><li>concomitant use with rifampicin, carbamazepine, phenytoin, phenobarbital, St John's Wort (hypericum perforatum); not recommended<\/li><li>falciparum malaria, severe; use not recommended<\/li><li>hepatic impairment, moderate to severe, with\/without jaundice; monitoring recommended<\/li><li>pregnancy; use not recommended unless no other suitable agents available<\/li><li>QT prolongation has occurred; increased risk in female patients, elderly patients, young children who are vomiting, and those receiving CYP3A4 substrates or inhibitors; monitoring recommended, particularly in patients with increased risk of developing arrhythmia<\/li><li>renal impairment, moderate to severe; monitoring recommended<\/li><\/ul>"},{"id":"930413-s-3-11","title":"Pregnancy Category","mono":"Unknown<br\/>"},{"id":"930413-s-3-12","title":"Breast Feeding","mono":"Unknown<br\/>"}]},"4":{"id":"930413-s-4","title":"Drug Interactions","sub":[{"id":"930413-s-4-13","title":"Contraindicated","mono":"<ul><li>Alfuzosin (theoretical)<\/li><li>Amifampridine (theoretical)<\/li><li>Amiodarone (theoretical)<\/li><li>Amitriptyline (theoretical)<\/li><li>Anagrelide (theoretical)<\/li><li>Apomorphine (theoretical)<\/li><li>Aripiprazole (theoretical)<\/li><li>Arsenic Trioxide (theoretical)<\/li><li>Asenapine (theoretical)<\/li><li>Astemizole (theoretical)<\/li><li>Atazanavir (theoretical)<\/li><li>Azithromycin (theoretical)<\/li><li>Bedaquiline (theoretical)<\/li><li>Bepridil (theoretical)<\/li><li>Buserelin (theoretical)<\/li><li>Chloroquine (theoretical)<\/li><li>Chlorpromazine (theoretical)<\/li><li>Ciprofloxacin (theoretical)<\/li><li>Cisapride (theoretical)<\/li><li>Citalopram (theoretical)<\/li><li>Clarithromycin (theoretical)<\/li><li>Clomipramine (theoretical)<\/li><li>Clozapine (theoretical)<\/li><li>Crizotinib (theoretical)<\/li><li>Cyclobenzaprine (theoretical)<\/li><li>Dabrafenib (theoretical)<\/li><li>Dasatinib (theoretical)<\/li><li>Degarelix (theoretical)<\/li><li>Delamanid (theoretical)<\/li><li>Desipramine (theoretical)<\/li><li>Deslorelin (theoretical)<\/li><li>Diphemanil (theoretical)<\/li><li>Disopyramide (theoretical)<\/li><li>Dofetilide (theoretical)<\/li><li>Dolasetron (theoretical)<\/li><li>Domperidone (theoretical)<\/li><li>Donepezil (theoretical)<\/li><li>Doxepin (theoretical)<\/li><li>Dronedarone (theoretical)<\/li><li>Droperidol (theoretical)<\/li><li>Ebastine (theoretical)<\/li><li>Eribulin (theoretical)<\/li><li>Erythromycin (theoretical)<\/li><li>Escitalopram (theoretical)<\/li><li>Famotidine (theoretical)<\/li><li>Felbamate (theoretical)<\/li><li>Fingolimod (theoretical)<\/li><li>Flecainide (theoretical)<\/li><li>Fluconazole (theoretical)<\/li><li>Fluoxetine (theoretical)<\/li><li>Formoterol (theoretical)<\/li><li>Foscarnet (theoretical)<\/li><li>Fosphenytoin (theoretical)<\/li><li>Galantamine (theoretical)<\/li><li>Gatifloxacin (theoretical)<\/li><li>Gemifloxacin (theoretical)<\/li><li>Gonadorelin (theoretical)<\/li><li>Goserelin (theoretical)<\/li><li>Granisetron (theoretical)<\/li><li>Halofantrine (theoretical)<\/li><li>Haloperidol (theoretical)<\/li><li>Histrelin (theoretical)<\/li><li>Hydroquinidine (theoretical)<\/li><li>Hydroxychloroquine (probable)<\/li><li>Ibutilide (theoretical)<\/li><li>Iloperidone (theoretical)<\/li><li>Imipramine (theoretical)<\/li><li>Itraconazole (theoretical)<\/li><li>Ivabradine (theoretical)<\/li><li>Ketoconazole (theoretical)<\/li><li>Lapatinib (theoretical)<\/li><li>Leuprolide (theoretical)<\/li><li>Levofloxacin (theoretical)<\/li><li>Levomethadyl (theoretical)<\/li><li>Lumefantrine (theoretical)<\/li><li>Mefloquine (theoretical)<\/li><li>Mesoridazine (theoretical)<\/li><li>Methadone (theoretical)<\/li><li>Mizolastine (theoretical)<\/li><li>Moxifloxacin (theoretical)<\/li><li>Nafarelin (theoretical)<\/li><li>Nilotinib (theoretical)<\/li><li>Norfloxacin (theoretical)<\/li><li>Octreotide (theoretical)<\/li><li>Ofloxacin (theoretical)<\/li><li>Olanzapine (theoretical)<\/li><li>Ondansetron (theoretical)<\/li><li>Paliperidone (theoretical)<\/li><li>Panobinostat (theoretical)<\/li><li>Paroxetine (theoretical)<\/li><li>Pasireotide (theoretical)<\/li><li>Pazopanib (theoretical)<\/li><li>Pentamidine (theoretical)<\/li><li>Perflutren Lipid Microsphere (theoretical)<\/li><li>Perphenazine (theoretical)<\/li><li>Phenytoin (theoretical)<\/li><li>Pimozide (theoretical)<\/li><li>Pipamperone (theoretical)<\/li><li>Posaconazole (theoretical)<\/li><li>Probucol (theoretical)<\/li><li>Procainamide (theoretical)<\/li><li>Prochlorperazine (theoretical)<\/li><li>Promethazine (theoretical)<\/li><li>Propafenone (theoretical)<\/li><li>Protriptyline (theoretical)<\/li><li>Quetiapine (theoretical)<\/li><li>Quinidine (theoretical)<\/li><li>Quinine (theoretical)<\/li><li>Ranolazine (theoretical)<\/li><li>Rilpivirine (theoretical)<\/li><li>Risperidone (theoretical)<\/li><li>Ritonavir (theoretical)<\/li><li>Saquinavir (theoretical)<\/li><li>Sertindole (theoretical)<\/li><li>Sevoflurane (theoretical)<\/li><li>Sodium Phosphate (theoretical)<\/li><li>Sodium Phosphate, Dibasic (theoretical)<\/li><li>Sodium Phosphate, Monobasic (theoretical)<\/li><li>Solifenacin (theoretical)<\/li><li>Sorafenib (theoretical)<\/li><li>Sotalol (theoretical)<\/li><li>Sparfloxacin (theoretical)<\/li><li>Sultopride (theoretical)<\/li><li>Sunitinib (theoretical)<\/li><li>Tacrolimus (theoretical)<\/li><li>Tamoxifen (theoretical)<\/li><li>Telavancin (theoretical)<\/li><li>Telithromycin (theoretical)<\/li><li>Terfenadine (theoretical)<\/li><li>Tetrabenazine (theoretical)<\/li><li>Thioridazine (theoretical)<\/li><li>Tolterodine (theoretical)<\/li><li>Toremifene (theoretical)<\/li><li>Trazodone (theoretical)<\/li><li>Trimipramine (theoretical)<\/li><li>Triptorelin (theoretical)<\/li><li>Vandetanib (theoretical)<\/li><li>Vardenafil (theoretical)<\/li><li>Vemurafenib (theoretical)<\/li><li>Venlafaxine (theoretical)<\/li><li>Vilanterol (theoretical)<\/li><li>Vinflunine (theoretical)<\/li><li>Voriconazole (theoretical)<\/li><li>Vorinostat (theoretical)<\/li><li>Ziprasidone (theoretical)<\/li><\/ul>"},{"id":"930413-s-4-14","title":"Major","mono":"<ul><li>Abiraterone (theoretical)<\/li><li>Ado-Trastuzumab Emtansine (theoretical)<\/li><li>Alfentanil (theoretical)<\/li><li>Alprazolam (theoretical)<\/li><li>Aminophylline (theoretical)<\/li><li>Amlodipine (theoretical)<\/li><li>Amobarbital (theoretical)<\/li><li>Amprenavir (theoretical)<\/li><li>Apixaban (theoretical)<\/li><li>Aprepitant (theoretical)<\/li><li>Armodafinil (theoretical)<\/li><li>Artemether (theoretical)<\/li><li>Atorvastatin (theoretical)<\/li><li>Bicalutamide (theoretical)<\/li><li>Boceprevir (theoretical)<\/li><li>Bosentan (theoretical)<\/li><li>Bosutinib (theoretical)<\/li><li>Brentuximab Vedotin (theoretical)<\/li><li>Brinzolamide (theoretical)<\/li><li>Bromocriptine (theoretical)<\/li><li>Budesonide (theoretical)<\/li><li>Buprenorphine (theoretical)<\/li><li>Buspirone (theoretical)<\/li><li>Butabarbital (theoretical)<\/li><li>Butalbital (theoretical)<\/li><li>Cabazitaxel (theoretical)<\/li><li>Cabozantinib (theoretical)<\/li><li>Carbamazepine (theoretical)<\/li><li>Cilostazol (theoretical)<\/li><li>Cimetidine (theoretical)<\/li><li>Clobazam (theoretical)<\/li><li>Cobicistat (theoretical)<\/li><li>Conivaptan (theoretical)<\/li><li>Cyclosporine (theoretical)<\/li><li>Darifenacin (theoretical)<\/li><li>Darunavir (theoretical)<\/li><li>Delavirdine (theoretical)<\/li><li>Dexamethasone (theoretical)<\/li><li>Dihydroergotamine (theoretical)<\/li><li>Diltiazem (theoretical)<\/li><li>Docetaxel (theoretical)<\/li><li>Doxorubicin (theoretical)<\/li><li>Doxorubicin Hydrochloride Liposome (theoretical)<\/li><li>Dutasteride (theoretical)<\/li><li>Efavirenz (theoretical)<\/li><li>Eletriptan (theoretical)<\/li><li>Eliglustat (theoretical)<\/li><li>Elvitegravir (theoretical)<\/li><li>Enzalutamide (theoretical)<\/li><li>Eplerenone (theoretical)<\/li><li>Ergotamine (theoretical)<\/li><li>Eslicarbazepine Acetate (theoretical)<\/li><li>Estradiol (theoretical)<\/li><li>Ethinyl Estradiol (theoretical)<\/li><li>Etravirine (theoretical)<\/li><li>Everolimus (theoretical)<\/li><li>Felodipine (theoretical)<\/li><li>Fentanyl (theoretical)<\/li><li>Fluticasone (theoretical)<\/li><li>Fluvoxamine (theoretical)<\/li><li>Fosamprenavir (theoretical)<\/li><li>Fosaprepitant (theoretical)<\/li><li>Ginkgo Biloba (theoretical)<\/li><li>Goldenseal (theoretical)<\/li><li>Hydrocodone (theoretical)<\/li><li>Hydrocortisone (theoretical)<\/li><li>Imatinib (theoretical)<\/li><li>Indinavir (theoretical)<\/li><li>Isoniazid (theoretical)<\/li><li>Letrozole (theoretical)<\/li><li>Levomilnacipran (theoretical)<\/li><li>Levonorgestrel (theoretical)<\/li><li>Lomitapide (theoretical)<\/li><li>Lopinavir (theoretical)<\/li><li>Losartan (theoretical)<\/li><li>Lovastatin (theoretical)<\/li><li>Lurasidone (theoretical)<\/li><li>Maraviroc (theoretical)<\/li><li>Medroxyprogesterone (theoretical)<\/li><li>Mephobarbital (theoretical)<\/li><li>Methohexital (theoretical)<\/li><li>Miconazole (theoretical)<\/li><li>Midazolam (theoretical)<\/li><li>Mifepristone (theoretical)<\/li><li>Mitotane (theoretical)<\/li><li>Modafinil (theoretical)<\/li><li>Nafcillin (theoretical)<\/li><li>Nateglinide (theoretical)<\/li><li>Nefazodone (theoretical)<\/li><li>Nelfinavir (theoretical)<\/li><li>Netupitant (theoretical)<\/li><li>Nevirapine (theoretical)<\/li><li>Nifedipine (theoretical)<\/li><li>Nisoldipine (theoretical)<\/li><li>Ospemifene (theoretical)<\/li><li>Oxycodone (theoretical)<\/li><li>Paclitaxel (theoretical)<\/li><li>Pentobarbital (theoretical)<\/li><li>Perampanel (theoretical)<\/li><li>Phenobarbital (theoretical)<\/li><li>Pioglitazone (theoretical)<\/li><li>Pomalidomide (theoretical)<\/li><li>Ponatinib (theoretical)<\/li><li>Prednisolone (theoretical)<\/li><li>Prednisone (theoretical)<\/li><li>Primidone (theoretical)<\/li><li>Ranitidine (theoretical)<\/li><li>Regorafenib (theoretical)<\/li><li>Rifabutin (theoretical)<\/li><li>Rifampin (theoretical)<\/li><li>Rifapentine (theoretical)<\/li><li>Roflumilast (theoretical)<\/li><li>Romidepsin (theoretical)<\/li><li>Rufinamide (theoretical)<\/li><li>Salmeterol (theoretical)<\/li><li>Saxagliptin (theoretical)<\/li><li>Secobarbital (theoretical)<\/li><li>Sildenafil (theoretical)<\/li><li>Siltuximab (theoretical)<\/li><li>Simvastatin (theoretical)<\/li><li>Sirolimus (theoretical)<\/li><li>St John's Wort (theoretical)<\/li><li>Tamsulosin (theoretical)<\/li><li>Telaprevir (theoretical)<\/li><li>Temsirolimus (theoretical)<\/li><li>Theophylline (theoretical)<\/li><li>Thiopental (theoretical)<\/li><li>Ticagrelor (theoretical)<\/li><li>Tipranavir (theoretical)<\/li><li>Tolvaptan (theoretical)<\/li><li>Topiramate (theoretical)<\/li><li>Trabectedin (theoretical)<\/li><li>Tramadol (theoretical)<\/li><li>Triamcinolone (theoretical)<\/li><li>Triazolam (theoretical)<\/li><li>Verapamil (theoretical)<\/li><li>Vilazodone (theoretical)<\/li><li>Vincristine (theoretical)<\/li><li>Vincristine Sulfate Liposome (theoretical)<\/li><li>Warfarin (theoretical)<\/li><li>Zaleplon (theoretical)<\/li><li>Zileuton (theoretical)<\/li><li>Zolpidem (theoretical)<\/li><\/ul>"}]},"5":{"id":"930413-s-5","title":"Adverse Effects","mono":"<b>Common<\/b><ul><li><b>Cardiovascular:<\/b>Prolonged QT interval (adults, 1% to less than 10%; pediatrics, 1% to less than 10%)<\/li><li><b>Immunologic:<\/b>Falciparum malaria (adults, 1% to less than 10%; pediatrics, 3% or greater), Influenza (pediatrics, 10% or greater)<\/li><li><b>Respiratory:<\/b>Cough (adults, 0.1% to less than 1%; pediatrics, 10% or greater)<\/li><li><b>Other:<\/b>Fever (adults, 1% to less than 10%; pediatrics, 1.5% or greater)<\/li><\/ul><b>Serious<\/b><ul><li><b>Cardiovascular:<\/b>Abnormal cardiac conduction (0.1% to less than 1%)<\/li><li><b>Gastrointestinal:<\/b>Necrotizing enterocolitis in fetus OR newborn, Leukocytoses (pediatrics, 1% to less than 10%)<\/li><li><b>Hematologic:<\/b>Leukocytosis, Necrotizing enterocolitis (pediatrics, 1% to less than 10%), Neutropenia (pediatrics, 1% to less than 10%), Thrombocytopenia (pediatrics, 1% to less than 10%)<\/li><li><b>Hepatic:<\/b>Hepatitis (0.1% to less than 1%)<\/li><li><b>Neurologic:<\/b>Seizure (0.1% to less than 1%)<\/li><\/ul>"},"6":{"id":"930413-s-6","title":"Drug Name Info","sub":{"2":{"id":"930413-s-6-19","title":"Class","mono":"Antimalarial<br\/>"},"3":{"id":"930413-s-6-20","title":"Regulatory Status","mono":"RX<br\/>"}}},"9":{"id":"930413-s-9","title":"Administration","mono":"<b>Oral<\/b><br\/><ul><li>take with water only and without food; take no less than 3 hours after any food intake; do not eat for 3 hours after taking each dose<\/li><li>tablets may be crushed, mixed with water, and given immediately for patients unable to swallow tablets<\/li><\/ul>"}}}